Endometrial Clear Cell Adenocarcinoma Clinical Trials

34 clinical trials for Endometrial Clear Cell Adenocarcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma — RECRUITING · PHASE3
• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma — RECRUITING · PHASE2
• Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers — RECRUITING
• Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer — RECRUITING · PHASE3
• Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer — ACTIVE_NOT_RECRUITING · NA
• Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer — TERMINATED · PHASE2
• Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer — COMPLETED · PHASE2
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — TERMINATED · PHASE1
• Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers — COMPLETED · PHASE1
• Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol — COMPLETED · PHASE3
• AMT-151 in Patients With Selected Advanced Solid Tumours — OTHER · PHASE1
• Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer — TERMINATED · PHASE2
• Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer — COMPLETED · PHASE2
• Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer — OTHER · PHASE3
• Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer — OTHER · PHASE2
• Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE1
• Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer — WITHDRAWN · PHASE2
• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer — OTHER · PHASE3
• Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer — COMPLETED · PHASE1
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer — COMPLETED · PHASE2
• Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer — COMPLETED · PHASE2
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer — COMPLETED · PHASE1
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — COMPLETED · PHASE3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — COMPLETED · PHASE1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — COMPLETED · PHASE1

Refine this search